Matthew James Zahka Fitzgerald, MS, LPC, NCC Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 419 Woodland Ave # Cottageb, Avon By The Sea, NJ 07717 Phone: 732-759-0707 |
News Archive
New research at the University of Leicester into how the brain controls the movements of limbs could prompt major advances in understanding the human brain and the development of prosthetic limbs.
Research led by The Ohio State University Wexner Medical Center and College of Medicine identified a new compound that might serve as a basis for developing a new class of drugs for diabetes.
A team of University of Pittsburgh mathematicians is using computational models to better understand how the structure of neural variability relates to such functions as short-term memory and decision making. In a paper published online April 2 in Proceedings of the National Academy of Sciences (PNAS), the Pitt team examines how fluctuations in brain activity can impact the dynamics of cognitive tasks.
For medicinal chemists, making tweaks to peptide structures is key to developing new drug candidates. Now, researchers have demonstrated that two iron-containing small-molecule catalysts can help turn certain types of amino acids - the building blocks of peptides and proteins - into an array of potential new forms, even when part of a larger peptide, while preserving a crucial aspect of their chemistry: chirality, or "handedness."
Halcyon Healthcare, a portfolio company of Health Evolution Partners, announced today the completion of two hospice acquisitions in central and northern Georgia. The acquired companies, Compassionate Hospice and Altus Healthcare & Hospice, mark the first two transactions for Halcyon. Halcyon was formed in 2010 by HEP, Dan Kohl and Jack Draughon to build a leading hospice and home health company in the Southeastern U.S.
› Verified 7 days ago